O-Linked N-Acetylglucosamine antibody | knockout validation | Abcam ab2739

This is a knockout-validated antibody summary, based on the publication "Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Mouse monoclonal IgG1, kappa

Company: Abcam

Antibody: O-Linked N-Acetylglucosamine

Catalog number: ab2739

Summary: Mouse monoclonal IgG1, kappa against pore complex-lamina fraction purified from rat liver nuclear envelopes. Suitable for western blot, immunoprecipitation (IP), immunocytochemistry/immunofluorescence, immunohistochemistry (frozen), ChromatinIP, and dot blot.

Validation Method

Immunohistochemistry

Sample

Liver, skeletal muscle and pancreas tissues from control Ogt-flox and Ogt-KO mice.

Primary incubation

1:200 dilution.

Figure

Immunohistochemical analysis of O-GlcNAcylation using anti-OGlcNAc (RL2) antibodies in multiple tissues (original magnification ×100). iWAT, inguinal white adipose tissue; N/D, not determined due to lean phenotype. Please see Figure 1b in the article [1].

References
  1. Ida S, Morino K, Sekine O, Ohashi N, Kume S, Chano T, et al. Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice.. Diabetologia. 2017;0: pubmed publisher